Clinical Trial Update: St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether St. John's Wort can relieve fatigue in cancer patients undergoing chemotherapy or hormone therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Drugs mentioned

• St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Status: COMPLETED